Table 1 Clinical parameters after ASCT according to presence or absence of ASIPs on serum IEF
From: Prognostic value of unrelated atypical serum immunofixation patterns during Multiple Myeloma therapy
Characteristics | Presence of ASIPs (n = 42) | Absence of ASIPs (n = 23) |
|---|---|---|
Age at dx (years) | 58 ± 5 | 54 ± 7a |
ASCT | ||
1 ASCT (n) 2 ASCT (n) | 11 (26.2 %) 31 (73.8 %) | 11 (47.8 %) 12 (52.2 %) |
Salmon-Durie (n) | ||
IA | 5 (11.9 %) | 0 |
IIA | 7 (16.7 %) | 5 (21.7 %) |
IIIA | 23 (54.8 %) | 13 (56.5 %) |
IIB | 2 (4.8 %) | 1 (4.3 %) |
IIIB | 5 (11.9 %) | 4 (17.4 %) |
ISS (n) | ||
I | 8 (19.0 %) | 3 (13.0 %) |
II | 22 (52.4 %) | 15 (65.2 %) |
III | 12 (28.6 %) | 5 (21.7 %) |
Relapses (n) | 29 (69.0 %) | 18 (78.3 %) |
Deaths (n) | 13 (31.0 %) | 14 (60.9 %)b |